An artist's view of drug‐induced hallucinosis
Identifieur interne : 004180 ( Main/Exploration ); précédent : 004179; suivant : 004181An artist's view of drug‐induced hallucinosis
Auteurs : Georg Ebersbach [Allemagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-07.
Descripteurs français
- Pascal (Inist)
- Wicri :
English descriptors
- KwdEn :
- Amantadine, Amantadine (administration & dosage), Amantadine (adverse effects), Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Artist, Case study, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Hallucination, Hallucinations (chemically induced), Hallucinations (psychology), Human, Humans, Medicine in Art, Middle Aged, Paint, Parkinson Disease (drug therapy), Parkinson Disease (psychology), Parkinson disease, Parkinson's disease, Perceptual Distortion (drug effects), Photography, Review, Toxicity, amantadine, hallucinations.
- MESH :
- chemical , administration & dosage : Amantadine, Antiparkinson Agents.
- chemical , adverse effects : Amantadine, Antiparkinson Agents.
- chemically induced : Hallucinations.
- drug effects : Perceptual Distortion.
- drug therapy : Parkinson Disease.
- psychology : Hallucinations, Parkinson Disease.
- Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Humans, Medicine in Art, Middle Aged, Photography.
Abstract
The occurrence of hallucinations in patients with Parkinson's disease is often related to antiparkinsonian therapy, but other factors such as cognitive decline and sleep‐cycle disturbances are thought to contribute. We describe an artist who depicted her visual hallucinations experienced in the course of Parkinson's disease. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10437
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C57
- to stream Istex, to step Curation: 001C57
- to stream Istex, to step Checkpoint: 002B10
- to stream PubMed, to step Corpus: 003744
- to stream PubMed, to step Curation: 003744
- to stream PubMed, to step Checkpoint: 003866
- to stream Ncbi, to step Merge: 000B07
- to stream Ncbi, to step Curation: 000B07
- to stream Ncbi, to step Checkpoint: 000B07
- to stream Main, to step Merge: 005E03
- to stream PascalFrancis, to step Corpus: 002435
- to stream PascalFrancis, to step Curation: 000886
- to stream PascalFrancis, to step Checkpoint: 002539
- to stream Main, to step Merge: 006085
- to stream Main, to step Curation: 004180
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">An artist's view of drug‐induced hallucinosis</title><author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D82398B3B43A5C0D1A0E340007AF8A7D7C83E858</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10437</idno><idno type="url">https://api.istex.fr/document/D82398B3B43A5C0D1A0E340007AF8A7D7C83E858/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001C57</idno><idno type="wicri:Area/Istex/Curation">001C57</idno><idno type="wicri:Area/Istex/Checkpoint">002B10</idno><idno type="wicri:doubleKey">0885-3185:2003:Ebersbach G:an:artist:s</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:12815666</idno><idno type="wicri:Area/PubMed/Corpus">003744</idno><idno type="wicri:Area/PubMed/Curation">003744</idno><idno type="wicri:Area/PubMed/Checkpoint">003866</idno><idno type="wicri:Area/Ncbi/Merge">000B07</idno><idno type="wicri:Area/Ncbi/Curation">000B07</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B07</idno><idno type="wicri:doubleKey">0885-3185:2003:Ebersbach G:an:artist:s</idno><idno type="wicri:Area/Main/Merge">005E03</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:03-0460562</idno><idno type="wicri:Area/PascalFrancis/Corpus">002435</idno><idno type="wicri:Area/PascalFrancis/Curation">000886</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002539</idno><idno type="wicri:doubleKey">0885-3185:2003:Ebersbach G:an:artist:s</idno><idno type="wicri:Area/Main/Merge">006085</idno><idno type="wicri:Area/Main/Curation">004180</idno><idno type="wicri:Area/Main/Exploration">004180</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">An artist's view of drug‐induced hallucinosis</title><author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Fachkrankenhaus für Bewegungsstörungen/Parkinson, Beelitz‐Heilstätten</wicri:regionArea><wicri:noRegion>Beelitz‐Heilstätten</wicri:noRegion><wicri:noRegion>Beelitz‐Heilstätten</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-07">2003-07</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="833">833</biblScope><biblScope unit="page" to="834">834</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D82398B3B43A5C0D1A0E340007AF8A7D7C83E858</idno><idno type="DOI">10.1002/mds.10437</idno><idno type="ArticleID">MDS10437</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amantadine</term><term>Amantadine (administration & dosage)</term><term>Amantadine (adverse effects)</term><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (adverse effects)</term><term>Artist</term><term>Case study</term><term>Dose-Response Relationship, Drug</term><term>Drug Therapy, Combination</term><term>Female</term><term>Hallucination</term><term>Hallucinations (chemically induced)</term><term>Hallucinations (psychology)</term><term>Human</term><term>Humans</term><term>Medicine in Art</term><term>Middle Aged</term><term>Paint</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (psychology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Perceptual Distortion (drug effects)</term><term>Photography</term><term>Review</term><term>Toxicity</term><term>amantadine</term><term>hallucinations</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Amantadine</term><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Amantadine</term><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Hallucinations</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Perceptual Distortion</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Hallucinations</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Dose-Response Relationship, Drug</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Medicine in Art</term><term>Middle Aged</term><term>Photography</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Amantadine</term><term>Article synthèse</term><term>Artiste</term><term>Etude cas</term><term>Hallucination</term><term>Homme</term><term>Parkinson maladie</term><term>Peinture</term><term>Toxicité</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term><term>Peinture</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The occurrence of hallucinations in patients with Parkinson's disease is often related to antiparkinsonian therapy, but other factors such as cognitive decline and sleep‐cycle disturbances are thought to contribute. We describe an artist who depicted her visual hallucinations experienced in the course of Parkinson's disease. © 2003 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Allemagne</li></country></list><tree><country name="Allemagne"><noRegion><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004180 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004180 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D82398B3B43A5C0D1A0E340007AF8A7D7C83E858
|texte= An artist's view of drug‐induced hallucinosis
}}
| This area was generated with Dilib version V0.6.23. |  |